Beijing, August 14 (Xinhua) Peru will join the covax facility, a new crown vaccine procurement plan, according to Peru’s “public opinion”. Under the plan, Peru will be able to provide vaccines to 20% of its population, or 6.6 million citizens. < / P > < p > the partnership, initially proposed by Japan, the UK, Germany, France and the European Union, is expected to raise a total of more than $20 billion, pay vaccine producers in advance and purchase vaccines for Member States. This global mechanism makes it easier for low-income countries to have fair access to the new coronavirus vaccine, according to the report. In Latin America, Bolivia, Ecuador and Colombia will also join the program. Antonio Prato, a member of the Peruvian vaccine command and a pharmaceutical expert, believes that despite the low price of the vaccine, the problem with such programs is that it takes longer for the vaccine to reach these countries. “In principle, the government is committed to providing doses to 3% of the population, and the doses will gradually increase to 20%, but no time has been set,” Prato warned According to Prato, what the Peruvian government needs to do is whether it joins the agreement or not, it should negotiate directly with the laboratory to ensure the latest dose of vaccination in early 2021. Patricia Garcia, a Peruvian epidemiologist and former health minister, stressed that the prime minister had announced an agreement with nine laboratories and that three laboratories would conduct clinical trials in Peru. These trials could give Peru experience in vaccines and even transfer technology in the future to produce vaccines in Peru.